Maxwell (Max) Mulcahy is a patient advocacy and engagement leader in the biopharmaceutical industry and currently serves as the head of patient advocacy at MorphoSys AG. Before joining the pharma industry, Max served as Senior Director of Strategic Initiatives at the Cancer Support Community (CSC) where he led a nationwide research study that examined the emotional needs of cancer patients receiving immunotherapy. Max also served as Senior Director for Patient and Professional Education at the Lymphoma Research Foundation (LRF). In this role he led LRF’s national patient education program series annually servicing thousands of lymphoma patients and caregivers. Max was also responsible for the development and creation of the Foundation’s national professional education portfolio. He holds a Bachelors of Arts in Political Science from Syracuse University.
Director, Global/ North American Patient Advocacy at Apellis